A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 105,175 shares of TEVA stock, worth $1.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
105,175
Previous 95,272 10.39%
Holding current value
$1.88 Million
Previous $1.34 Million 27.16%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$12.78 - $17.4 $126,560 - $172,312
9,903 Added 10.39%
105,175 $1.71 Million
Q1 2024

May 02, 2024

BUY
$10.67 - $14.43 $107,628 - $145,555
10,087 Added 11.84%
95,272 $1.34 Million
Q4 2023

Feb 01, 2024

SELL
$8.12 - $10.63 $2,736 - $3,582
-337 Reduced 0.39%
85,185 $889,000
Q3 2023

Oct 30, 2023

BUY
$7.48 - $10.7 $2,169 - $3,103
290 Added 0.34%
85,522 $872,000
Q2 2023

Aug 04, 2023

SELL
$7.2 - $9.47 $3,520 - $4,630
-489 Reduced 0.57%
85,232 $641,000
Q1 2023

May 02, 2023

BUY
$8.36 - $11.37 $69,730 - $94,837
8,341 Added 10.78%
85,721 $758,000
Q3 2022

Oct 19, 2022

BUY
$6.86 - $11.95 $56,972 - $99,244
8,305 Added 12.02%
77,380 $624,000
Q2 2022

Jul 13, 2022

BUY
$7.38 - $10.4 $107,725 - $151,808
14,597 Added 26.79%
69,075 $519,000
Q1 2022

Apr 19, 2022

SELL
$7.33 - $9.39 $92,401 - $118,370
-12,606 Reduced 18.79%
54,478 $512,000
Q4 2021

Jan 20, 2022

BUY
$7.9 - $10.19 $77,277 - $99,678
9,782 Added 17.07%
67,084 $537,000
Q3 2021

Oct 15, 2021

SELL
$8.38 - $10.18 $3,687 - $4,479
-440 Reduced 0.76%
57,302 $558,000
Q2 2021

Jul 19, 2021

SELL
$9.9 - $11.56 $46,421 - $54,204
-4,689 Reduced 7.51%
57,742 $571,000
Q1 2021

May 07, 2021

BUY
$10.34 - $12.81 $71,066 - $88,043
6,873 Added 12.37%
62,431 $720,000
Q4 2020

Feb 02, 2021

SELL
$8.61 - $11.04 $23,651 - $30,326
-2,747 Reduced 4.71%
55,558 $536,000
Q3 2020

Oct 29, 2020

SELL
$8.57 - $12.69 $1,268 - $1,878
-148 Reduced 0.25%
58,305 $525,000
Q2 2020

Aug 12, 2020

SELL
$8.12 - $13.12 $42,832 - $69,208
-5,275 Reduced 8.28%
58,453 $720,000
Q1 2020

Apr 21, 2020

BUY
$6.69 - $13.45 $19,655 - $39,516
2,938 Added 4.83%
63,728 $572,000
Q4 2019

Jan 24, 2020

BUY
$6.53 - $10.72 $27,765 - $45,581
4,252 Added 7.52%
60,790 $595,000
Q3 2019

Oct 16, 2019

BUY
$6.16 - $9.6 $2,833 - $4,416
460 Added 0.82%
56,538 $388,000
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $46,056 - $89,163
-5,672 Reduced 9.19%
56,078 $517,000
Q1 2019

May 07, 2019

BUY
$15.58 - $20.01 $88,915 - $114,197
5,707 Added 10.18%
61,750 $968,000
Q4 2018

Jan 25, 2019

SELL
$14.59 - $23.84 $61,526 - $100,533
-4,217 Reduced 7.0%
56,043 $864,000
Q3 2018

Oct 15, 2018

SELL
$21.06 - $25.65 $24,998 - $30,446
-1,187 Reduced 1.93%
60,260 $1.3 Million
Q2 2018

Jul 31, 2018

BUY
$16.77 - $24.71 $72,278 - $106,500
4,310 Added 7.54%
61,447 $1.49 Million
Q1 2018

Apr 25, 2018

SELL
$16.68 - $22.07 $31,358 - $41,491
-1,880 Reduced 3.19%
57,137 $976,000
Q4 2017

Jan 25, 2018

SELL
$11.23 - $19.1 $67,312 - $114,485
-5,994 Reduced 9.22%
59,017 $1.12 Million
Q3 2017

Oct 27, 2017

BUY
$15.41 - $32.17 $1 Million - $2.09 Million
65,011
65,011 $1.14 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.